Filing Flows › Idexx Laboratories (IDXX) › Q3 2026 › vs Q3 2025
Idexx Laboratories (IDXX) Q3 2026 vs Q3 2025 (year over year)
Idexx Laboratories's revenue rose $109M (+10%) from $1.1B in Q3 2025 to $1.2B in Q3 2026. The biggest changes: Product revenue +$66.7M (+10%); Service revenue +$42.3M (+9%). Gross margin 62.9% against 61.8% (+1.1 pts).
Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 62.9% | 61.8% | +1.1 pts |
| Operating margin | 33.1% | 32.1% | +1.0 pts |
| Net margin | 26.1% | 24.8% | +1.3 pts |
| Free cash flow margin | 34.7% | 33.6% | +1.1 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Product revenue | $723M | $656M | $66.7M | +10% |
| Service revenue | $491M | $449M | $42.3M | +9% |
| Revenue | $1.2B | $1.1B | $109M | +10% |
| Gross profit | $764M | $683M | $80.9M | +12% |
| Cost of revenue | $450M | $422M | $28.1M | +7% |
| Operating profit | $402M | $355M | $47.5M | +13% |
| Operating expenses | $362M | $329M | $33.4M | +10% |
| Pre-tax earnings | $399M | $345M | $54.6M | +16% |
| Research & development | $68.8M | $63.4M | $5.4M | +9% |
| Sales & marketing | $170M | $159M | $10.7M | +7% |
| General & admin | $123M | $106M | $17.3M | +16% |
| Net earnings | $317M | $275M | $42.5M | +15% |
| Income tax | $82.2M | $70.2M | $12.0M | +17% |
| Depreciation & amortization | $40.6M | $36.6M | $3.9M | +11% |
| Share-based compensation | $16.2M | $14.4M | $1.8M | +12% |
| Working capital & other | $75.8M | $76.7M | −$877K | -1% |
| Operating cash flow | $450M | $402M | $47.4M | +12% |
| Free cash flow (OCF − capex) | $421M | $371M | $49.6M | +13% |
| Capital expenditures | $28.9M | $31.1M | −$2.2M | -7% |
Questions
How much did Idexx Laboratories's revenue grow year over year in Q3 2026?
Idexx Laboratories's revenue rose $109M (+10%) from $1.1B in Q3 2025 to $1.2B in Q3 2026.
What drove Idexx Laboratories's revenue change in Q3 2026?
Product revenue +$66.7M (+10%); Service revenue +$42.3M (+9%).